Skip to content

Risk Minimisation Materials

Search for Risk Minimisation Materials...

You can search the eMC for Risk Minimisation Materials (RMMs) by

  • Company
  • Common medicine name
  • Title of Risk Minimisation Material

List all materials for medicines starting with:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Result: Risk Minimisation Materials for medicines starting with the letter A

Certain risk materials on this website are intended for use by healthcare professionals only.

By proceeding you are confirming that you are a healthcare professional.

Want to avoid this message? If you are a Healthcare professional, REGISTER or LOGIN and you will not have to self-certify when you access Risk Minimisation Materials.

Abstral

Kyowa Kirin Ltd

Abstral Patient and Carer Guide

Abstral (fentanyl citrate) sublingual tablets - Important risk minimisation information for patients and their carers

Abstral Prescriber Guide

Abstral (fentanyl citrate) sublingual tablets - Important risk minimisation information for healthcare professionals

For Healthcare Professionals

Adasuve

Galen Limited

Adasuve HCP Guide - HCP use

Adasuve HCP Guide - HCP use

For Healthcare Professionals

Alenini

Actavis UK Ltd

Alenvona

Actavis UK Ltd

Alzest

Dr. Reddy's Laboratories (UK) Ltd

Amfexa

Flynn Pharma Ltd

Amfexa - Educational Risk Minimisation Materials to help reduce the risk with using this medicine.

HEALTHCARE PROFESSIONALS GUIDE TO PRESCRIBING WEBSITE
Website to host materials for healthcare professionals to support appropriate prescribing of dexamfetamine sulphate

For Healthcare Professionals

Angiox

The Medicines Company UK Ltd

Angiox-PPCI- Dosing and Administration Card - UK-Oct2016

Dosing and administration instructions for PCI and primary PCI

For Healthcare Professionals

Angiox-Pre-Cath- Dosing and Administration Card - UK-Oct2016

Dosing and administration instructions for medically managed ACS patients with urgent or early intervention

For Healthcare Professionals

Arava

SANOFI

RMP Patient Leaflet

Risk Management Educational Material

Aripiprazole

Accord Healthcare Limited

Aripiprazole Accord Educational leaflet for Patients and Caregivers

Patient and Caregiver risk minimisation educational leaflet for Aripiprazole Accord 5mg, 10mg, 15mg and 30mg Tablets.
For further information please contact our medical information department
Medical Information e-mail: uk@accord-healthcare.com
Medical Information Fax: +44 (0)208 861 4867
Medical Information Direct Line: +44 (0)208 901 3370

Aripiprazole Accord HCP Q&A Brochure

Healthcare Professional Q&A Brochure for Aripiprazole Accord 5mg, 10mg, 15mg and 30mg Tablets.
For further information please contact our medical information department
Medical Information e-mail: uk@accord-healthcare.com
Medical Information Fax: +44 (0)208 861 4867
Medical Information Direct Line: +44 (0)208 901 3370

For Healthcare Professionals
Actavis UK Ltd

Aripiprazole (Patient-Caregiver) Brochure

This booklet will help you and your caregiver(s) understand what
Aripiprazole is and why it was chosen for you, as well as what to expect during
treatment. This booklet also includes information about potential side effects
associated with Aripiprazole treatment and the importance of immediately
reporting any symptoms of these side effects to your doctor.

Aripiprazole FAQ Brochure

These frequently asked questions are provided by Actavis for doctors, nurses
and other healthcare professionals who use Aripiprazole to treat adolescent
patients with bipolar I disorder.
This document will enable you to:
• Understand how Aripiprazole is used to treat adolescent patients with
bipolar I disorder
• Provide important information to adolescent patients with bipolar I
disorder and their caregiver(s)
• Understand potential adverse reactions in adolescent patients with bipolar
I disorder who are treated with Aripiprazole
• Present the Patient/Caregiver Information Brochure and its objectives to
adolescent patients with bipolar I disorder

For Healthcare Professionals
Aspire Pharma Ltd

Aripiprazole Educational leaflet for patients and caregivers

Patient and caregiver risk minimisation leaflet for Aripiprazole Pharmathen 5mg, 10mg,15mg and 30mg tablets. For Hard copies, please contact Aspire Pharma Ltd (Tel: 01730 231148).

Aripiprazole HCP Q&A Brochure

Healthcare professional Q&A Brochure for Aripirazole Pharmathen 5mg, 10mg, 15mg 30mg Tablets. For Hard copies, please contact Aspire Pharma Ltd (01730 231148).

For Healthcare Professionals
Dr. Reddy's Laboratories (UK) Ltd

FAQ - Aripiprazole

Educational materials for the Healthcare Professional

For Healthcare Professionals

Your Guide to Aripiprazole

Patient/Caregiver Information Brochure

Zentiva

Aripiprazole Zentiva Educational leaflet for Patients/Caregivers

Patient and Caregiver risk minimisation educational leaflet for Aripiprazole Zentiva 5mg, 10mg, 15mg and 30mg Tablets.
For hard copies please contact our medical information department at 0845 372 7101 or email uk-medicalinformation@sanofi.com .

Aripiprazole Zentiva HCP Q&A Brochure

Healthcare Professional Q&A Brochure for Arpiprazole Zentiva 5mg, 10mg, 15mg and 30mg Tablets.
For hard copies please contact our medical information department at 0845 372 7101 or email
uk-medicalinformation@sanofi.com .

For Healthcare Professionals

Aubagio

Genzyme Therapeutics

Aubagio (teriflunomide) – Healthcare professional (HCP) – Education / Discussion Guide - Risk Minimisation Information for Healthcare Professionals

At first prescription, the prescriber/healthcare professional (HCP) should discuss with the patient the risks described within the discussion guide.

For Healthcare Professionals

Aubagio (teriflunomide) – Patient Card - Risk Minimisation Information for Patients

The Patient Card contains important safety information the patient needs to be aware of when receiving treatment with Aubagio (teriflunomide). At first prescription, the prescriber/healthcare professional (HCP) should provide the Patient Card.

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue